SCHEMBL1746834

SCHEMBL1746834

CCC(=O)Nc1nc2c(s1)CCc1ccccc1-2

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.77
POLB P06746 1/20 0.75
KMT2A Q03164 5/20 0.74
MAPT P10636 5/20 0.67
MEN1 O00255 4/20 0.67
KDM4E B2RXH2 4/20 0.67
ALDH1A1 P00352 3/20 0.67
XIAP P98170 1/20 0.67
LMNA P02545 5/20 0.63
NPC1 O15118 4/20 0.63
RAB9A P51151 4/20 0.63
USP2 O75604 1/20 0.63
HTT P42858 1/20 0.63
NPSR1 Q6W5P4 1/20 0.63
SMN1; SMN2 Q16637 4/20 0.61
HSD17B10 Q99714 1/20 0.61
HPGD P15428 2/20 0.59
GAA P10253 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
ALOX12 P18054 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14276660 0.81 KMT2A (0.65) ALOX5POLBKMT2AMAPTMEN1
SCHEMBL14276667 0.81 KMT2A (0.65) ALOX5POLBKMT2AMAPTMEN1
SCHEMBL4957325 0.79 MAPT (0.71) ALOX5POLBKMT2AMAPTMEN1
SCHEMBL27101609 0.79 ALOX5 (0.61) ALOX5POLBKMT2AMAPTMEN1
SCHEMBL1744879 0.78 POLB (0.61) ALOX5POLBKMT2AMAPTMEN1
SCHEMBL14276658 0.78 ALOX5 (0.60) ALOX5POLBKMT2AMAPTMEN1
SCHEMBL30953836 0.78 POLB (0.64) ALOX5POLBKMT2AMAPTMEN1
SCHEMBL4963803 0.76 MAPT (0.67) ALOX5POLBKMT2AMAPTMEN1
SCHEMBL27834222 0.76 POLB (0.58) ALOX5POLBKMT2AMAPTMEN1
SCHEMBL27622010 0.75 POLB (0.54) ALOX5POLBKMT2AMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1559422-B1 RECEPTOR FUNCTION CONTROLLING AGENT TAKEDA PHARMACEUTICAL (JP) 2014-04-30 EP disclosed
EP-2385032-A1 GPR40 Receptor function regulator Takeda Pharmaceutical Company Limited (JP) 2011-11-09 EP disclosed
US-7960369-B2 Receptor function regulator TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-06-14 US disclosed
US-20090012093-A1 Receptor Function Regulator TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-01-08 US disclosed
CN-1735408-A Receptor function controlling agent TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2006-02-15 CN disclosed
EP-1559422-A1 RECEPTOR FUNCTION CONTROLLING AGENT Takeda Pharmaceutical Company Limited (JP) 2005-08-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090012093-A1 Receptor Function Regulator GPR119, GIPR, INSR ALOX5 3500/4885POLB 4877/4885KMT2A 4408/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.